Woodline Partners LP
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1784547
San Francisco, CA
Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$45,265,886
-$4,880,964 QoQ
Shares Held
72,595
+11.7% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#131
of 1,322 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. REGN ranks #32 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,002,863 | $375,096,182 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $173,349,326 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
4,000,567 | $125,057,724 | |
| 4 | BHVN |
Biohaven Ltd.
|
7,660,280 | $113,984,966 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,603,162 | $100,742,369 | |
| 6 | CYTK |
Cytokinetics Inc
|
1,100,708 | $93,769,314 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
3,007,798 | $92,730,412 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,500,673 | $88,498,817 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,265,886 | 72,595 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $50,146,850 | 64,968 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $34,278,228 | 60,964 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $30,858,450 | 58,778 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $67,366,007 | 106,217 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $73,568,730 | 103,279 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $104,511,127 | 99,417 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $191,179,203 | 181,897 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $164,202,718 | 170,602 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $149,388,346 | 170,090 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $112,393,293 | 136,572 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $34,247,053 | 47,662 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $126,800,936 | 154,321 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $115,072,604 | 159,493 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $129,064,616 | 187,357 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $31,206,934 | 52,792 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $73,679,119 | 105,494 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $56,992,153 | 90,246 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $45,900,482 | 75,846 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $43,487,365 | 77,859 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $87,956,252 | 185,899 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $9,760,754 | 20,204 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $19,159,775 | 30,722 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $13,416,744 | 27,477 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||